Immune checkpoint inhibitors targeting PD-1 and PD-L1 have revolutionized cancer therapy, delivering long-term survival benefits in several malignancies. However, nearly half of patients show limited ...

Research is shaking up how we think about evolution, suggesting there's a level of predictability influenced by genes and genetic history.

UC San Diego professor Ludmil Alexandrov will lead an international team of scientists awarded $25 million to research cancer mutations. The award comes from Cancer Grand Challenges, a collaboration ...

We have a vested interest in protecting our communities and everyone in them. “Medical freedom” is the antithesis of community.

As a world leader in the immuno-oncology field, Dr. Zihai Li has long been at the forefront of cancer immunotherapy.

In Britain young people are now considered one of the most at-risk groups of bowel cancer , but experts say diet, lifestyle, ...

Scientists have discovered more than 140 medications that alter the gut microbiome, forcing bacteria to compete for nutrients, a phenomenon known to cause an intestinal imbalance and prompt ...

Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance. Emerging research reveals that the ...

Explore new findings on ovarian cancer and how blocking focal adhesion kinase can enhance immune response in treatment.

In the evolutionary history of life, the ability of a cell to separate its inner world from the external environment was an important turning point. The so-called plasma membrane lets cells control ...